"Hyperandrogenism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
Descriptor ID |
D017588
|
MeSH Number(s) |
C12.706.316.064.500 C12.706.316.129.750 C13.351.875.253.064.500 C13.351.875.253.129.750 C16.131.939.316.064.500 C16.131.939.316.129.750 C19.391.119.064.500 C19.391.119.129.750
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperandrogenism".
Below are MeSH descriptors whose meaning is more specific than "Hyperandrogenism".
This graph shows the total number of publications written about "Hyperandrogenism" by people in this website by year, and whether "Hyperandrogenism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 4 | 5 |
2018 | 0 | 1 | 1 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperandrogenism" by people in Profiles.
-
SARS-CoV-2 Viral Entry Proteins in Hyperandrogenemic Female Mice: Implications for Women with PCOS and COVID-19. Int J Mol Sci. 2021 Apr 25; 22(9).
-
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19. J Eur Acad Dermatol Venereol. 2021 Feb; 35(2):e101-e104.
-
Coronavirus Disease 2019 (SARS-CoV-2) and polycystic ovarian disease: Is there a higher risk for these women? J Steroid Biochem Mol Biol. 2021 01; 205:105770.
-
[Androgens and Antiandrogens influence on COVID-19 disease in men]. Probl Endokrinol (Mosk). 2020 10 01; 66(4):77-81.
-
Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic. BMC Med. 2020 07 15; 18(1):220.
-
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev. 2018 12; 31(2):291-301.
-
Hyperandrogenemia and ovarian reserve in patients with Mayer-Rokitansky-Küster-Hauser syndrome type 1 and 2: potential influences on ovarian stimulation. Arch Gynecol Obstet. 2018 02; 297(2):513-520.
-
Obstructive sleep apnoea and polycystic ovary syndrome: A comprehensive review of clinical interactions and underlying pathophysiology. Clin Endocrinol (Oxf). 2017 Oct; 87(4):313-319.
-
Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years. Reprod Biomed Online. 2017 Sep; 35(3):331-339.
-
Mullerian dysgenesis: a critical review of the literature. Arch Gynecol Obstet. 2017 Jun; 295(6):1369-1381.